Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank100
3Y CAGR+6.0%
5Y CAGR+7.8%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
+6.0%/yr
vs +12.2%/yr prior
5Y CAGR
+7.8%/yr
Consistent
Acceleration
-6.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.95B | +838.1% |
| 2024 | $-535.60M | -114.8% |
| 2023 | $3.62B | +9.0% |
| 2022 | $3.32B | +41.8% |
| 2021 | $2.34B | -13.6% |
| 2020 | $2.71B | +130.4% |
| 2019 | $1.18B | -43.9% |
| 2018 | $2.10B | +695.8% |
| 2017 | $263.48M | +335.1% |
| 2016 | $-112.05M | - |